Project Grant F31MH143283
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded a K23 career development grant totaling $378,984 to the University of Pittsburgh under the Mental Health Research Grants program (CFDA 93.242), effective March 13, 2026, through February 28, 2031. This award funds a five-year research investigation into the neurobiological mechanisms underlying adolescent suicidal ideation (SI), addressing a critical public health gap given that suicide is the leading cause of...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of Pittsburgh a $185,552 Project Grant effective September 19, 2025, under the Mental Health Research Grants program (CFDA 93.242) to investigate neurocognitive responses to social threat and their connection to suicidality in adolescent girls. The research will generate scientific knowledge through a K23 mentored research career development award examining how sustained neural responsivity to...
- Federal Project Grant Award Summary Oregon Health & Science University (OHSU) received a $109,076 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded on December 19, 2025, with a completion date of July 31, 2029. This research project, titled "Internalizing Symptoms in Adolescence: Understanding the Roles of Negative Life Events, Emotion Regulation, and the Brain Over Time," will generate...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded a Project Grant totaling $180,360 to The Trustees of Columbia University in the City of New York (Health Sciences Division) under the Mental Health Research Grants program (CFDA 93.242). The award, effective May 11, 2026 through April 30, 2031, funds the design and testing of a brief single-session intervention (SSI) for adolescents with depression. The project adapts Interpersonal Psychotherapy for Adolescents...
- Project Summary The National Institute of Mental Health (NIMH) awarded a $436,934 Project Grant (CFDA 93.242: Mental Health Research Grants) to the University of California, Los Angeles effective June 1, 2026, through May 31, 2028. This R21 research project will deliver longitudinal analytical research examining suicidal thoughts and behaviors (STBs) trajectories in Mexican-origin youth, leveraging an existing 19-year dataset from the California Families Project covering 674 participants...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of Illinois a $100,228 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to implement suicide prevention interventions in outpatient pediatric behavioral health settings. The project, initiated September 30, 2026 and concluding May 31, 2028, addresses the gap between clinical practice guidelines recognizing providers' responsibility to implement evidence-based practices...
- SUMMARY The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded the University of Rhode Island $1,403,716 on September 20, 2025, under the Alcohol Research Programs (CFDA 93.273) to conduct a five-year longitudinal study examining the temporal and proximal relationships between acute alcohol use and suicide risk during community reentry. The research applies ecological momentary assessment (EMA) and transdermal alcohol sensor technology (BACtrack Skyn) to track real-time changes...
- Project Grant Summary The National Institute of Mental Health (NIMH) awarded The Ohio State University $433,125 under the Mental Health Research Grants program (CFDA 93.242) for a two-year research project spanning July 1, 2026 through June 30, 2028. This R21 exploratory grant funds empirical research to identify and test modifiable mechanisms linking chronic pain and suicide risk in adults. The study will recruit 90 individuals with chronic musculoskeletal pain and elevated suicide risk to...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke awarded a K23 Career Development Award of $198,129 to the University of Colorado-Denver, effective August 18, 2025, through July 31, 2030, under the Drug Use and Addiction Research Programs (CFDA 93.279). This award supports a feasibility trial and career development initiative focused on a remotely-delivered mindfulness-based intervention (MBI) adapted for adolescents with migraine. The principal...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded University of Colorado-Denver a Project Grant of $601,576 under the Mental Health Research Grants program (CFDA 93.242) on May 15, 2025, with completion scheduled for May 14, 2028. This three-year R34 developmental grant supports the iterative development and pilot evaluation of SURE-KIDS, the first outpatient, research-supported treatment intervention specifically designed for preadolescents experiencing...
ENDOCANNABINOIDS, STRESS RESPONSE, AND PREFRONTAL ENGAGEMENT DURING EMOTION REGULATION IN ADOLESCENT SUICIDAL IDEATION - PROJECT SUMMARY SUICIDE IS A CRITICAL PUBLIC HEALTH CONCERN, PARTICULARLY AMONG ADOLESCENTS, WHERE IT RANKS AS THE SECOND- LEADING CAUSE OF DEATH. SUICIDAL IDEATION (SI), WHICH PEAKS IN LATE ADOLESCENCE, TYPICALLY PRECEDES SUICIDE ATTEMPTS AND STRONGLY PREDICTS SUICIDE RISK. MITIGATING THIS RISK IN ADOLESCENTS IS CHALLENGING, AS MANY FAIL TO DISCLOSE SI AND CURRENT TREATMENTS DO NOT FULLY ADDRESS SI-RELATED CONCERNS. FURTHERMORE, SI CAN BE PRECIPITATED BY PSYCHOSOCIAL STRESS, WHICH BECOMES MORE PREVALENT DURING ADOLESCENCE, AND MAY BE EXACERBATED BY DIFFICULTIES REGULATING EMOTIONAL RESPONSES TO STRESS. EMERGING RESEARCH SUGGESTS THAT THE ENDOCANNABINOID (ECB) SYSTEM, WHICH PLAYS A CRITICAL ROLE IN REGULATING STRESS AND EMOTIONAL RESPONSES, MAY BE ALTERED IN ADULTS AT RISK FOR SUICIDE. HOWEVER, THE ROLE OF THE ECB SYSTEM IN ADOLESCENT SUICIDE RISK REMAINS UNDEREXPLORED. THE PROPOSED STUDY AIMS TO ADDRESS THIS GAP BY COMPARING ECB SYSTEM FUNCTION AT REST AND IN RESPONSE TO STRESS IN ADOLESCENTS (AGES 14-17 YEARS) WITH AND WITHOUT SI, AND LINK CIRCULATING ECBS TO PREFRONTAL EMOTION REGULATION PROCESSES IN THE SI GROUP. IT IS HYPOTHESIZED THAT ADOLESCENTS WITH SI WILL EXHIBIT HIGHER RESTING ECB CONCENTRATIONS BUT A BLUNTED ECB RESPONSE TO ACUTE PSYCHOSOCIAL STRESS COMPARED WITH CONTROLS. FURTHER, IT IS PREDICTED THAT ECB SYSTEM ALTERATIONS WILL BE LINKED TO GREATER DORSOLATERAL PREFRONTAL CORTEX (DLPFC) ENGAGEMENT DURING COGNITIVE REAPPRAISAL, AN AREA AND FORM OF EMOTION REGULATION ASSOCIATED WITH DYSFUNCTION IN YOUTH WITH SI. TO TEST THESE HYPOTHESES, 30 ADOLESCENTS WITH SI AND MODERATE DEPRESSIVE SYMPTOMS AND 30 MATCHED CONTROLS WITHOUT SI (MATCHED FOR DEPRESSIVE SYMPTOMS, AGE, AND SEX) WILL BE RECRUITED TO THIS TWO-DAY STUDY. ON THE FIRST DAY, PARTICIPANTS WILL COMPLETE THE TRIER SOCIAL STRESS TEST (A PSYCHOSOCIAL STRESSOR), WITH BLOOD SAMPLES COLLECTED BEFORE AND AFTER THE TASK. THE FOLLOWING DAY, ADOLESCENTS WILL COMPLETE A COGNITIVE REAPPRAISAL TASK DURING FUNCTIONAL NEUROIMAGING TO ASSESS DLPFC ENGAGEMENT. COMPLEMENTARY DATA, INCLUDING PSYCHIATRIC SYMPTOMS, RELATED LIPIDS, AND ADDITIONAL TASK-BASED AND RESTING- STATE FMRI DATA WILL BE COLLECTED. THIS RESEARCH WILL ELUCIDATE THE ROLE OF THE ECB SYSTEM AS IT RELATES TO STRESS AND EMOTION REGULATION IN ADOLESCENTS WITH SI, WHICH MAY CONTRIBUTE TO IMPROVEMENTS IN RISK DETECTION AND TREATMENTS. THE MENTORSHIP TEAM, CONSISTING OF EXPERTS IN ADOLESCENT SI, PEDIATRIC NEUROIMAGING, CHILD/ADOLESCENT PSYCHIATRY, BIOSTATISTICS, AND ECBS, IS UNIQUELY POSITIONED TO GUIDE PI ELY IN THIS PROJECT. THE PROPOSED TRAINING AND RESEARCH PLAN WILL PROVIDE PI ELY WITH THE KNOWLEDGE AND SKILLS THAT ARE CRITICAL FOR HER TO EXPAND THIS WORK INTO A POSTDOCTORAL RESEARCH FELLOWSHIP, SUPPORTING HER GOAL OF DEVELOPING AN INDEPENDENT RESEARCH CAREER FOCUSED ON IMPROVING SI RISK DETECTION AND TREATMENTS IN ADOLESCENTS.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 3/5/26 | ||
| Not listed | $49.5k | 3/5/26 | ||
| Not listed | $49.5k | 3/5/26 |